Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-03 · accession 0000899243-22-021234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-06-06 | 2022-06-03 | KPTI | Mason Michael | EVP, CFO, Treas | S - Sale | $6.04 | -601 | 138.5K | -0.4% | -$3,630 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | S | D | 3 | $6.07 | 138,509 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-03 | S | D | 598 | $6.04 | 138,512 | D | — | — |